InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-24.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by McDonough John, Director. Insider active across 1 company, notably T2 Biosystems, Inc.. In total, 4 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €36k. Activity tracked since 1 July 2021. The latest transaction was disclosed on 1 July 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
18,182 shares@ US$1.1650.0% of flowCommon StockSEC:0000899243-21-027184
18,182 shares@ US$1.1679.35% mcap50.0% of flowCommon StockSEC:0000899243-21-027184:0
45,454 sharesCommon StockSEC:0000899243-21-026529:0
45,454 sharesCommon StockSEC:0000899243-21-026529
4 of 4 declarations
About McDonough John
John McDonough is a Board Member at T2 Biosystems, Inc. He contributes to the governance of the company by bringing his expertise in the health technology sector. John plays a key role in evaluating growth strategies and overseeing development initiatives. His industry experience is a valuable asset to T2 Biosystems' management team.
